The North America Oxidative Stress Assay Market would witness market growth of 8.6% CAGR during the forecast period (2023-2030).
The US market dominated the North America Oxidative Stress Assay Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $497 million by 2030. The Canada market is experiencing a CAGR of 11.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2023 - 2030).
The utilization of this is of the utmost importance when examining the involvement of oxidative stress in developing a wide range of diseases. These diseases include cardiovascular disorders, cancer, diabetes, and neurodegenerative disorders (e.g., Alzheimer's and Parkinson's).
Moreover, it helps assess the antioxidant capacity of foods and nutritional supplements, providing valuable information about their potential health benefits. Researchers use this to investigate how dietary components influence oxidative stress levels and overall cellular health.
According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017.
Based on Product, the market is segmented into Consumables, Instruments, and Services. Based on Test Type, the market is segmented into Indirect Assays, Antioxidant Capacity Assays, Enzyme-Based Assays, and Reactive Oxygen Species-Based Assays. Based on Technology, the market is segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, Chromatography, Microscopy, and Others. Based on Disease Type, the market is segmented into Cardiovascular Disease, Respiratory Diseases, Cancer, Diabetes, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Industries, Contract Research Organizations, Academic Research Institutes, Clinical Laboratories, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Oxidative Stress Assay Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $497 million by 2030. The Canada market is experiencing a CAGR of 11.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2023 - 2030).
The utilization of this is of the utmost importance when examining the involvement of oxidative stress in developing a wide range of diseases. These diseases include cardiovascular disorders, cancer, diabetes, and neurodegenerative disorders (e.g., Alzheimer's and Parkinson's).
Moreover, it helps assess the antioxidant capacity of foods and nutritional supplements, providing valuable information about their potential health benefits. Researchers use this to investigate how dietary components influence oxidative stress levels and overall cellular health.
According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017.
Based on Product, the market is segmented into Consumables, Instruments, and Services. Based on Test Type, the market is segmented into Indirect Assays, Antioxidant Capacity Assays, Enzyme-Based Assays, and Reactive Oxygen Species-Based Assays. Based on Technology, the market is segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, Chromatography, Microscopy, and Others. Based on Disease Type, the market is segmented into Cardiovascular Disease, Respiratory Diseases, Cancer, Diabetes, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Industries, Contract Research Organizations, Academic Research Institutes, Clinical Laboratories, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Abcam Plc (Danaher Corporation)
- Merck KGaA
- Promega Corporation
- Qiagen N.V
- Thermo Fisher Scientific, Inc.
- Cayman Chemical Company, Inc.
- AMS Biotechnology (Europe) Limited.
- Cell Biolabs, Inc.
- Enzo Life Sciences, Inc. (Enzo Biochem, Inc.)
- ImmunoChemistry Technologies
Market Report Segmentation
By Product- Consumables
- Instruments
- Services
- Indirect Assays
- Antioxidant Capacity Assays
- Enzyme-Based Assays
- Reactive Oxygen Species-Based Assays
- Enzyme-linked Immunosorbent Assay (ELISA)
- Flow Cytometry
- Chromatography
- Microscopy
- Others
- Cardiovascular Disease
- Respiratory Diseases
- Cancer
- Diabetes
- Others
- Pharmaceutical & Biotechnology Industries
- Contract Research Organizations
- Academic Research Institutes
- Clinical Laboratories
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Oxidative Stress Assay Market by Product
Chapter 5. North America Oxidative Stress Assay Market by Test Type
Chapter 6. North America Oxidative Stress Assay Market by Technology
Chapter 7. North America Oxidative Stress Assay Market by Disease Type
Chapter 8. North America Oxidative Stress Assay Market by End-user
Chapter 9. North America Oxidative Stress Assay Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Abcam Plc (Danaher Corporation)
- Merck KGaA
- Promega Corporation
- Qiagen N.V
- Thermo Fisher Scientific, Inc.
- Cayman Chemical Company, Inc.
- AMS Biotechnology (Europe) Limited.
- Cell Biolabs, Inc.
- Enzo Life Sciences, Inc. (Enzo Biochem, Inc.)
- ImmunoChemistry Technologies
Methodology
LOADING...
